Volume 8 -
pbp 2026, 8 - : 0-0 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ahmadi H, Keshavarz A, Khaksarian M. Medicinal Plants Traditionally Used for the Management of Anxiety in Iranian Medicine. pbp 2026; 8 (In press)
URL: http://pbp.medilam.ac.ir/article-1-353-en.html
URL: http://pbp.medilam.ac.ir/article-1-353-en.html
1- Department of Psychiatry, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran
2- Department of Psychology, Torbat-e Jam Branch, Islamic Azad University, Torbat-e Jam, Iran
3- Department of Physiology, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran ,mojkhaksar@yahoo.com
2- Department of Psychology, Torbat-e Jam Branch, Islamic Azad University, Torbat-e Jam, Iran
3- Department of Physiology, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran ,
Abstract: (19 Views)
Objective: Anxiety is a common psychological disorder that significantly impacts individuals' quality of life. Traditional Iranian Medicine (TIM) has long utilized medicinal plants to offer natural and low-side-effect treatments for anxiety management. This study aims to identify and review the medicinal plants effective in reducing anxiety based on traditional Iranian medical texts and to explore their mechanisms of action.
Methods: In this review, reputable books of traditional Iranian medicine and herbal pharmacopoeias, as well as online scientific databases, were systematically examined. Data were collected and analyzed focusing on medicinal plants with documented anxiolytic properties.
Results: Medicinal plants identified include Melissa officinalis L., Valeriana officinalis L., Borago officinalis L., Lavandula angustifolia Mill., Crocus sativus L., Matricaria chamomilla L., Zingiber officinale Roscoe, Cinnamomum verum J. Presl, Foeniculum vulgare Mill., Glycyrrhiza glabra L., Passiflora incarnata L., Origanum majorana L., Camellia sinensis (L.) Kuntze, Rosmarinus officinalis L., Hypericum perforatum L., Elaeagnus angustifolia L., Rosa damascena Mill., Berberis vulgaris L., Silybum marianum (L.) Gaertn., Melissa officinalis L., Anethum graveolens L., Alcea rosea L., Valeriana montana Scop., Salix alba L., Rosa spp., Boswellia serrata Roxb., and Cichorium intybus L.. These plants exhibit significant anxiolytic and sedative effects through modulation of the central nervous system, hormonal regulation, and sleep improvement.
Conclusion: The findings indicate that medicinal plants from traditional Iranian medicine may serve as safe and effective approaches for anxiety treatment. However, further clinical studies are recommended to scientifically validate their efficacy.
Methods: In this review, reputable books of traditional Iranian medicine and herbal pharmacopoeias, as well as online scientific databases, were systematically examined. Data were collected and analyzed focusing on medicinal plants with documented anxiolytic properties.
Results: Medicinal plants identified include Melissa officinalis L., Valeriana officinalis L., Borago officinalis L., Lavandula angustifolia Mill., Crocus sativus L., Matricaria chamomilla L., Zingiber officinale Roscoe, Cinnamomum verum J. Presl, Foeniculum vulgare Mill., Glycyrrhiza glabra L., Passiflora incarnata L., Origanum majorana L., Camellia sinensis (L.) Kuntze, Rosmarinus officinalis L., Hypericum perforatum L., Elaeagnus angustifolia L., Rosa damascena Mill., Berberis vulgaris L., Silybum marianum (L.) Gaertn., Melissa officinalis L., Anethum graveolens L., Alcea rosea L., Valeriana montana Scop., Salix alba L., Rosa spp., Boswellia serrata Roxb., and Cichorium intybus L.. These plants exhibit significant anxiolytic and sedative effects through modulation of the central nervous system, hormonal regulation, and sleep improvement.
Conclusion: The findings indicate that medicinal plants from traditional Iranian medicine may serve as safe and effective approaches for anxiety treatment. However, further clinical studies are recommended to scientifically validate their efficacy.
Type of Study: Review/Systemtic review |
Subject:
Ethno-pharmacology
Received: 2025/09/11 | Accepted: 2025/09/14 | Published: 2026/01/20
Received: 2025/09/11 | Accepted: 2025/09/14 | Published: 2026/01/20
References
1. Khaksarian M, Mirr I, Kordian S, Nooripour R, Ahangari N, Masjedi-Arani A. A comparison of methylphenidate (MPH) and combined methylphenidate with Crocus sativus (Saffron) in the treatment of children and adolescents with ADHD: A randomized, double-blind, parallel-group, clinical trial. Iran J Psychiatry Behav Sci. 2021 Jul 31. doi: https://doi.org/10.5812/ijpbs.108390
2. Shiravand F, Hasanvand S, Sahl Abadi M, Khaksarian M. Effect of transcranial direct current stimulation on neurological and psychiatric diseases. Yafteh. 2024 Oct 10;26(3):13-35. doi: 10.32592/Yafteh.2024.26.3.13
3. Rahmani M, Mahvelati A, Farajinia AH, Shahyad S, Khaksarian M, Nooripour R, et al. Comparison of vitamin D, neurofeedback, and neurofeedback combined with vitamin D supplementation in children with Attention-Deficit/Hyperactivity disorder. Arch Iran Med. 2022 May 1;25(5):285. doi: 10.34172/aim.2022.47.
4. Amirzargar N, Heidari-Soureshjani S, Yang Q, Abbaszadeh S, Khaksarian M. Neuroprotective effects of medicinal plants in cerebral hypoxia and anoxia: A systematic review. Nat Prod J. 2020 Oct 1;10(5):550-65. doi:10.2174/2210315509666190820103658
5. Pour MR, Babaeenezhad E, Hadavand S, Elahian M, Alekasir A, Khaksarian M. Anti-inflammatory properties of chitosan hydrogel containing Satureja khuzestanica jamzad essential oil on the animal model. Herb Med J. 2023;8(3):133-43. doi: 10.22087/hmj.v8i3.1017
6. Ghorbanzadeh V, Jafarpour A, Pirnia A, Pajouhi N, Khaksarian M, Veiskarami S, et al. The role of vasopressin V1A and oxytocin OTR receptors in protective effects of arginine vasopressin against H2O2-induced oxidative stress in H9C2 cells. Arch Physiol Biochem. 2022 May 4;128(3):830-5. doi: 10.1080/13813455.2020.1729816.
7. Craske MG, Rauch SL, Ursano R, Prenoveau J, Pine DS, Zinbarg RE. What is an anxiety disorder? Focus. 2011 Jul;9(3):369-88.
8. Levitt EE. The psychology of anxiety. Routledge; 2015 Sep 25.
9. Julian LJ. Measures of anxiety. Arthritis Care Res. 2011 Nov;63(Suppl 11): 10-2. doi: 10.1002/acr.20561
10. Chorpita BF, Barlow DH. The development of anxiety: The role of control in the early environment. In: The Neurotic Paradox. Vol 2. 2018 Oct 24. p. 227-64.
11. Adwas AA, Jbireal JM, Azab AE. Anxiety: Insights into signs, symptoms, etiology, pathophysiology, and treatment. East Afr Scholars J Med Sci. 2019 Oct 23;2(10):580-91.
12. Sweeney M, Pine D, Ollendick TH, March JS. Etiology of fear and anxiety. In: Phobic and Anxiety Disorders in Children and Adolescents: A Clinician’s Guide to Effective Psychosocial and Pharmacological Interventions. 2004 Jan 15. p. 34-60.
13. Michael T, Zetsche U, Margraf J. Epidemiology of anxiety disorders. Psychiatry. 2007 Apr 1;6(4):136-42.
14. Bandelow B, Michaelis S. Epidemiology of anxiety disorders in the 21st century. Dialog Clin Neurosci. 2015 Sep 30;17(3):327-35.
15. Charney DS, Deutch A. A functional neuroanatomy of anxiety and fear: implications for the pathophysiology and treatment of anxiety disorders. Crit Rev Neurobiol. 1996;10(3-4).
16. Ressler KJ, Nemeroff CB. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety. 2000;12(S1):2-19. doi: 10.1002/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4.
17. Emilien G, Durlach C, Lepola U, Dinan T. Anxiety disorders: pathophysiology and pharmacological treatment. Springer; 2002 Mar 1.
18. Murrough JW, Yaqubi S, Sayed S, Charney DS. Emerging drugs for the treatment of anxiety. Expert Opin Emerg Drugs. 2015 Jul 3;20(3):393-406.
19. Bandelow B, Michaelis S, Wedekind D. Treatment of anxiety disorders. Dialog Clin Neurosci. 2017 Jun 30;19(2):93-107. doi: 10.31887/DCNS.2017.19.2/bbandelow.
20. Nutt DJ. Overview of diagnosis and drug treatments of anxiety disorders. CNS Spectr. 2005 Jan;10(1):49-56. doi: 10.1017/s1092852900009901.
21. Bandelow B. Current and novel psychopharmacological drugs for anxiety disorders. In: Anxiety Disorders: Rethinking and Understanding Recent Discoveries. 2020 Jan 31. p. 347-65. doi: 10.1007/978-981-32-9705-0_19.
22. Uhlenhuth EH, Alexander PE, Dempsey GM, Jones W, Coleman BS, Swiontek AM. Medication side effects in anxious patients: negative placebo responses? J Affect Disord. 1998 Jan 1;47(1-3):183-90. doi: 10.1016/s0165-0327(97)00125-0
23. Vogel G. A worrisome side effect of an antianxiety remedy. Science. 2001;37:37.
24. Guzmán Gutiérrez SL, Reyes Chilpa R, Bonilla Jaime H. Medicinal plants for the treatment of “nervios”, anxiety, and depression in Mexican Traditional Medicine. Rev Bras Farmacogn. 2014;24(5):591-608.
25. Lee SH, Kang MJ, Lim JH, Seong WY. A review study in treatment for anxiety disorder in traditional Chinese medicine. J Orient Neuropsychiatry. 2012;23(2):1-2.
26. Liu L, Liu C, Wang Y, Wang P, Li Y, Li B. Herbal medicine for anxiety, depression and insomnia. Curr Neuropharmacol. 2015 Jul 1;13(4):481-93. doi: 10.2174/1570159X1304150831122734
27. Amin G. Popular Medicinal Plants of Iran. Tehran: Tehran Univ Med Sci Press; 2005.
28. Nadkarni KM. Indian Materia Medica. Vol. 2. Mumbai: Popular Prakashan; 1996.
29. Avicenna. The Canon of Medicine (Al-Qanun fi al-Tibb). New York: AMS Press; 1973.
30. Chaghmini M. Qanunche-ye Chaghmini (The Small Canon of Chaghmini). Qom: Jalaleddin Publications; 2008.
31. Zargari A. Medicinal Plants. Vol. 1. Tehran: Tehran Univ Press; 1990.
32. Ghahraman A. Flora of Iran. Tehran: Research Institute of Forests and Rangelands; 2001.
33. Qarshi I. Al-Asbab wa al-Alamat (Causes and Symptoms). Tehran: Academy of Medical Sciences of Iran; 2008.
34. Nadkarni KM. Indian Materia Medica. Vol. 1. Mumbai: Popular Prakashan; 1996.
35. Ibn al-Baytar. Al-Jami li-Mufradat al-Adwiyah wa al-Aghdhiyah. Beirut: Dar al-Kotob al-Ilmiyah; 1992.
36. Zargari A. Medicinal Plants. Vol. 2. Tehran: Tehran Univ Press; 1991.
37. Tonkaboni M. Tohfat al-Mo’menin (Gift to the Believers). Tehran: Shahid Beheshti Univ Med Sci Press; 2007.
38. Azizi M, Fathi Najafi M. Ethnobotany and Medicinal Plants of Iran. Mashhad: Ferdowsi Univ Mashhad Press; 2015.
39. Rhazes (Al-Razi). Kitab al-Hawi fi al-Tibb (The Comprehensive Book on Medicine). London: Routledge; 1996.
40. Chopra RN, Nayar SL, Chopra IC. Glossary of Indian Medicinal Plants. New Delhi: Council of Scientific and Industrial Research; 1996.
41. Khorasani MA. Exir-e Azam (The Great Elixir). Tehran: Iranian Traditional Med Soc Press; 2011.
42. Jorjani SE. Zakhireh Kharazmshahi (The Treasure of Kharazmshah). Tehran: Iranian Cultural Heritage Org Press; 2001.
43. Mozaffarian V. Identification of Medicinal and Aromatic Plants of Iran. Tehran: Farhang Moaser; 2013.
44. Aghili Khorasani MH. Makhzan al-Adwiyah (Treasury of Drugs). Tehran: Tehran Univ Med Sci Press; 2009.
45. Zargari A. Medicinal Plants. Vol. 4. Tehran: Tehran Univ Press; 1993.
46. Shafiee A, Jafarabady K, Seighali N, Mohammadi I, Rajai Firouz Abadi S, Abhari FS, et al. Effect of saffron versus selective serotonin reuptake inhibitors (SSRIs) in treatment of depression and anxiety: A meta-analysis of randomized controlled trials. Nutr Rev. 2025 Mar;83(3): 751-61. doi: 10.1093/nutrit/nuae076.
47. Mendis K, Gnanapragasam MA, Keerthirathne DH, Madushani LA, Piyasekara GM, Senanayake S, et al. Neuropharmacology and the applications of herbal extracts found within Sri Lankan traditional anxiety remedies. Phytomed Plus. 2025 Mar 29:100794.
48. Anonymous. Phytotherapy for anxiety in Iran: a review of the most important anti-anxiety medicinal plants. J Chem Pharm Sci. 2016;9(3):1235-41.
49. Rabbani M, Vaseghi G, Sajjadi SE, Amin B. Persian herbal medicines with anxiolytic properties. J Med Plants. 2011 Summer;10(39):7-11.
50. Saki K, Goudarzi Z, Mazaheri Y, Shokri S, Parsaei P, et al. Identification of plant flora affecting anti-anxiety and anti-depression disorders based on ethnobotanical knowledge of the Arasbaran region, Azerbaijan, Iran. Adv Life Sci. 2022;9(4):589-94. https://www.als-journal.com/9430-22/
51. Nikfarjam M, Bahmani M, Heidari-Soureshjani S. Phytotherapy for anxiety in Iran: a review of the most important anti-anxiety medicinal plants. J Chem Pharm Sci. 2016;9(3):1235-41.
52. Afsahi A, Miremadi M. P143: A review on the effects of certain anti-anxiety and sedative herbs. Shefaye Khatam. 2014;2(S1):167. Available from: http://shefayekhatam.ir/article-1-270-en.html
53. Abbaszadeh S, Teimouri H, Farzan B. An ethnobotanical study of medicinal plants with antianxiety and antidepressant effects in Shahrekord. Egypt J Vet Sci. 2019;50(1):81-87. doi:10.21608/ejvs.2019.12612.1077
54. Saki K, Bahmani M, Rafieian-Kopaei M, Hassanzadazar H, Dehghan K, Bahmani F, et al. The most common native medicinal plants used for psychiatric and neurological disorders in Urmia city, northwest of Iran. Asian Pac J Trop Dis. 2014;4: 2222-1808. doi:10.1016/S2222-1808(14)60754-4
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |